A new trading day began on Tuesday, with Alkermes plc (NASDAQ: ALKS) stock price down -0.25% from the previous day of trading, before settling in for the closing price of $27.55. ALKS’s price has ranged from $22.22 to $32.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 10.61% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 82.21%. With a float of $158.75 million, this company’s outstanding shares have now reached $166.98 million.
In an organization with 2100 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.31%, operating margin of 20.77%, and the pretax margin is 22.07%.
Alkermes plc (ALKS) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Alkermes plc is 1.89%, while institutional ownership is 111.12%. The most recent insider transaction that took place on Nov 11 ’24, was worth 1,774,576. In this transaction EVP R&D, Chief Medical Officer of this company sold 58,996 shares at a rate of $30.08, taking the stock ownership to the 83,300 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Officer proposed sale 58,996 for $30.08, making the entire transaction worth $1,774,578.
Alkermes plc (ALKS) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.22 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.21% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Here are Alkermes plc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.95. Likewise, its price to free cash flow for the trailing twelve months is 14.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.96, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 1.78 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.52 million. That was inferior than the volume of 1.83 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 15.34%. Additionally, its Average True Range was 0.94.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 61.89%, which indicates a significant increase from 39.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.83% in the past 14 days, which was higher than the 35.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.81, while its 200-day Moving Average is $26.58. However, in the short run, Alkermes plc’s stock first resistance to watch stands at $27.78. Second resistance stands at $28.07. The third major resistance level sits at $28.41. If the price goes on to break the first support level at $27.15, it is likely to go to the next support level at $26.81. Assuming the price breaks the second support level, the third support level stands at $26.52.
Alkermes plc (NASDAQ: ALKS) Key Stats
With a market capitalization of 4.45 billion, the company has a total of 161,803K Shares Outstanding. Currently, annual sales are 1,663 M while annual income is 355,760 K. The company’s previous quarter sales were 378,140 K while its latest quarter income was 92,380 K.
